Doctor profile · Federal record
Dr. SUREKHA GANGASANI, M.D.
Rheumatology Physician (CMS: RHEUMATOLOGY) · MCKINNEY, TX
- NPI 1437255619
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 39 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1445 HERITAGE DR, STE A
MCKINNEY, TX 750693394
(972) 547-9700
fax (972) 547-1110
Credentials & registration
- NPI registered
- September 2006 — 20 yrs on file
- Profile last updated
- February 13, 2020
- Year of graduation
- 1987 — 39 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Texas #J9676
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1437255619. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,731
Distinct HCPCS
10
Medicare allowed
$180,542
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 3,480 | 33 | $22 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 437 | 198 | $121 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 214 | 142 | $87 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 120 | 36 | $1 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 112 | 13 | $27 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 79 | 17 | $124 | |
J7050 |
Infusion, normal saline solution, 250 cc | 79 | 19 | $1 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 70 | 33 | $69 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 59 | 59 | $162 | |
96372 |
Injection of drug or substance under skin or into muscle | 41 | 36 | $13 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 391. This provider delivers 12× the peer median.Open Payments
Industry payments received
All-time total
$1,937
Transactions
89
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen Inc. | 29 | $504.42 | |
| ABBVIE INC. | 13 | $363.06 | |
| PFIZER INC. | 8 | $226.41 | |
| Mallinckrodt Hospital Products Inc. | 13 | $197.57 | |
| Lilly USA, LLC | 9 | $174.32 | |
| Janssen Scientific Affairs, LLC | 1 | $142.35 | |
| AstraZeneca Pharmaceuticals LP | 3 | $76.17 | |
| GlaxoSmithKline, LLC. | 3 | $54.24 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $44.25 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43.74 | |
| Novartis Pharmaceuticals Corporation | 2 | $31.10 | |
| Janssen Biotech, Inc. | 1 | $22.67 | |
| SCILEX PHARMACEUTICALS INC. | 1 | $21.04 | |
| Alexion Pharmaceuticals, Inc. | 1 | $19.01 | |
| Fresenius Kabi USA, LLC | 1 | $17.07 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,719
Patients
528
Total drug cost
$446,943
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 305 | 91 | $10,303 |
| Hydroxychloroquine Sulfate | Generic | 266 | 87 | $15,174 |
| Prednisone | Generic | 239 | 76 | $1,753 |
| Tramadol Hcl | Generic | 148 | 27 | $849 |
| Leflunomide | Generic | 115 | 34 | $9,235 |
| Gabapentin | Generic | 102 | 30 | $1,175 |
| Folic Acid | Generic | 101 | 30 | $545 |
| Alendronate Sodium | Generic | 89 | 33 | $790 |
| Sulfasalazine | Generic | 80 | 24 | $2,319 |
| Celecoxib | Generic | 63 | 18 | $1,626 |